PEG-liposomal doxorubicin as a potential agent for canine metastatic osteosarcoma – in vitro and ex ovo studies
Authors
Magdalena Walewska
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Anna Małek
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Bartosz Taciak
Department of Cancer Biology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland
Anna Wojtalewicz
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Sylwia Wilk
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Agata Wojtkowska
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Katarzyna Zabielska-Koczywąs
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
Roman Lechowski
Department of Small Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
DOI: https://doi.org/10.2478/jvetres-2023-0026 | Journal eISSN: 2450-8608
Language: English
Page range: 297 - 305
Submitted on: Feb 15, 2023
Accepted on: Apr 19, 2023
Published on: Jun 16, 2023
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2023 Magdalena Walewska, Anna Małek, Bartosz Taciak, Anna Wojtalewicz, Sylwia Wilk, Agata Wojtkowska, Katarzyna Zabielska-Koczywąs, Roman Lechowski, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.